4727
was cooled to 0ꢀC and treated with NaN3 (1.9 g, 29 mmol). The mixture was stirred at rt for 5 days, diluted with
EtOAc and washed with H2O and brine. The aqueous layer was extracted with EtOAc. The organic layers were
dried (MgSO4), ®ltered, and chromatographed on SiO2 (1.5:1, EtOAc:hexanes) to aord 125 mg (13%) of 7, 600
mg (53%) of 13 and 250 mg (22%) of 14 as waxy solids: compound 13: [ꢀ]D ^42.3 (c 1.0, CHCl3); IR (neat) 3434
(br), 2108, 1708 cm^1; 1H NMR (500 MHz, CDCl3) ꢁ 7.39±7.29 (m, 5H), 5.23±5.19 (m, 1H), 5.09 and 4.99 (2 d, 1H,
J=12.1 Hz), 4.91 and 4.51 (2 bs, 1H), 4.51±4.45 (m, 1H), 4.30 and 4.18 (2 dd, 1H, J=7.3 Hz), 4.14 and 4.08 (2 dd,
1H, J=5.3, 11.9 Hz), 3.88 and 3.58 (2 s, 3H), 3.04 and 2.89 (2 dd, 1H, J=6.4, 15.4 Hz), 2.77±2.71 (m, 1H), 2.69±
2.58 (m, 1H), 2.42±2.32 and 2.21±2.17 (m, 1H), 2.42±2.32 (m, 1H), 2.21±2.17 (m, 1H); 13C NMR (125 MHz,
CDCl3) ꢁ 204.5, 203.9, 175.0, 174.5, 154.4, 154.0, 135.6, 128.5, 128.4, 128.3, 128.2, 127.9, 81.4, 80.5, 67.8, 67.5,
64.1, 63.5, 61.7, 57.7, 57.6, 53.2, 52.8, 44.1, 43.0, 42.2, 41.9, 35.6, 34.3; HRMS m/z calcd for C18H20N4O6:
388.1383, found: 388.1368.
11. Rawal, V. H.; Zhong, H. M. Tetrahedron Lett. 1994, 35, 4947.
12. Chung, B. Y.; Park, Y. S.; Cho, I. S.; Hyun, B. C. Bull. Korean Chem. Soc. 1988, 9, 269.
13. Attempted conversion of the minor isomer 14 under analogous conditions failed to produce the expected diol and
instead returned a complex mixture of products.
14. 5-(R)-[2-(R)-tert-Butyl-dimethyl-silanyloxy)-3-cyano-propyl]-4-oxo-pyrrolidine-1,2-dicarboxylic acid 1-benzyl ester
2-methyl ester (18). Iodobenzene diacetate (45 mg, 0.14 mmol) and iodine (35 mg, 0.14 mmol) were added
sequentially at rt to a solution of hydroxy azide 17 (27 mg, 0.054 mmol) in 1.2 mL of CH2Cl2. The purple solution
was stirred for 3 h, diluted with EtOAc and washed with saturated aqueous NaHCO3 and 10% aqueous Na2S2O3.
The aqueous phase was extracted with EtOAc. The combined organic layers were dried (MgSO4), ®ltered, and
chromatographed on SiO2 (1:3, EtOAc:hexanes) to aord 15 mg (59%) of 18 as an oil and 3 mg (ꢂ10%) of 17
contaminated with an unknown by-product. Compound 18: [ꢀ]D ^45.0 (c 1.0, CHCl3); IR (neat) 2249, 1758, 1712
cm^1; 1H NMR (500 MHz, CDCl3) ꢁ 7.38±7.34 (m, 5H), 5.31±5.22 (m, 1H), 5.16±5.09 (m, 1H), 4.72 (d, 1H, J=6.2
Hz), 4.28±4.11 (m, 2H), 3.76 and 3.53 (2 s, 3H), 2.97 (dd, 1H, J=6.2, 11.2 Hz), 2.60±2.45 (m, 2H), 2.50±2.30 (m,
2H), 2.00±1.90 and 1.80±1.72 (2 m, 1H), 0.91 and 0.85 (2 s, 9H), 0.14±0.01 (m, 6H); 13C NMR (125 MHz, CDCl3)
ꢁ 209.1, 208.6, 172.2, 155.5, 154.7, 135.6, 128.6, 128.4, 117.2, 116.7, 68.1, 67.6, 65.1, 63.9, 59.3, 58.3, 55.9, 55.8,
52.7, 52.6, 39.7, 39.5, 39.4, 39.1, 26.7, 26.4, 25.6, 17.9, ^4.6, ^4.8; HRMS m/z calcd for C24H34N2O6Si: 474.2186,
found: 474.2181.